Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.004 per share ("Shares")
-
Shares outstanding
-
22,866,677
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
24,236,173
-
Shares change
-
+702,435
-
Total reported value, excl. options
-
$618,449,426
-
Value change
-
+$18,484,148
-
Put/Call ratio
-
2033%
-
Number of buys
-
38
-
Number of sells
-
-38
-
Price
-
$25.52
Significant Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q2 2023
104 filings reported holding BCYC - BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") as of Q2 2023.
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,236,173 shares
.
Largest 10 shareholders include Deep Track Capital, LP (2,819,045 shares), Paradigm Biocapital Advisors LP (1,985,430 shares), Jefferies Financial Group Inc. (1,948,000 shares), First Light Asset Management, LLC (1,739,449 shares), MORGAN STANLEY (1,439,567 shares), TYBOURNE CAPITAL MANAGEMENT (HK) LTD (1,281,820 shares), JANUS HENDERSON GROUP PLC (1,281,324 shares), Candriam S.C.A. (1,273,261 shares), Sio Capital Management, LLC (968,671 shares), and ARMISTICE CAPITAL, LLC (876,000 shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.